Director of the Centers for Disease Control and Preven-
tion, shall develop a system to collect data on juvenile dia-
betes, including with respect to incidence and prevalence,
and shall establish a national database for such data.
(b) LONG-TERM EPIDEMIOLOGY STUDIES ON JUVE-
NILE DIABETES.—
(1) 
IN
GENERAL.—The 
Secretary, 
acting
through the Director of the National Institutes of
Health, shall conduct or support long-term epidemi-
ology studies in which individuals with type 1, or ju-
venile, diabetes are followed for 10 years or more.
Such studies shall, in order to provide a valuable re-
source for the purposes specified in paragraph (2),
provide for complete characterization of disease
manifestations, appropriate medical history, eluci-
dation of environmental factors, delineation of com-
plications, results of usual medical treatment and a
variety of other potential valuable (such as samples
of blood).
(2) PURPOSES.—The purposes referred to in
paragraph (1) with respect to type 1 diabetes are
the following:
(A) Delineation of potential environmental
triggers thought precipitating or causing type 1
diabetes.
(B) Delineation of those clinical character-
istics or lab measures associated with complica-
tions of the disease.
(C) Potential study population to enter
into clinical trials for prevention and treatment,
as well as genetic studies.
(c) TYPE 2 DIABETES IN YOUTH.—The Secretary,
acting through the Director of the Centers for Disease
Control and Prevention, shall implement a national public
health effort to address type 2 diabetes in youth,
including—
(1) enhancing surveillance systems and expand-
ing research to better assess the prevalence of type
2 diabetes in youth and determine the extent to
which type 2 diabetes is incorrectly diagnosed as
type 1 diabetes among children; and
(2) assisting States in establishing coordinated
school health programs and physical activity and nu-
trition demonstration programs to control weight
and increase physical activity among youth.
(d) CLINICAL TRIAL INFRASTRUCTURE/INNOVATIVE
TREATMENTS FOR JUVENILE DIABETES.—The Secretary,
acting through the Director of the National Institutes of
Health, shall support regional clinical centers for the cure
of juvenile diabetes and shall through such centers provide
for—
(1) well-characterized population of children ap-
propriate for study;
(2) well-trained clinical scientists able to con-
duct such trials;
(3) appropriate clinical settings able to house
such studies; and
(4) appropriate statistical capability, data, safe-
ty and other monitoring capacity.
(e) DEVELOPMENT
OF VACCINE.—The Secretary,
acting through the appropriate agencies of the Public
Health Service, shall provide for a national effort to de-
velop a vaccine for type 1 diabetes. Such effort shall pro-
vide for a combination of increased efforts in research and
development of candidate vaccines, coupled with appro-
priate ability to conduct large clinical trials in children.
(f) LOAN REPAYMENT PROGRAM.—Part G of title IV
of the Public Health Service Act (42 U.S.C. 288 et seq.)
is amended by inserting after section 487E the following
section:
‘‘LOAN REPAYMENT PROGRAM FOR RESEARCH ON
DIABETES IN CHILDREN
‘‘SEC. 487F. (a) IN GENERAL.—The Secretary, in
consultation with the Director of the National Institute
of Diabetes and Digestive and Kidney Diseases, shall es-
tablish a program of entering into contracts with qualified
health professionals (including graduate students) under
which such health professionals agree to conduct research
regarding diabetes in children in consideration of the Fed-
eral Government agreeing to repay, for each year of such
service, not more than $35,000 of the principal and inter-
est of the educational loans of such health professionals.
‘‘(b) ADJUSTMENTS REGARDING COST OF LIVING.—
With respect to the limitation established in subsection (a)
on the annual amount of repayment that may be made,
the Secretary may make such periodic adjustments to the
limitation to reflect increases in the cost of living as the
Secretary deems necessary.
‘‘(c) APPLICABILITY
OF CERTAIN PROVISIONS.—
With respect to the National Health Service Corps Loan
Repayment Program established in subpart III of part D
of title III, the provisions of such subpart shall, except
as inconsistent with subsection (a) of this section, apply
to the program established in such subsection (a) in the
same manner and to the same extent as such provisions
apply to the National Health Service Corps Loan Repay-
ment Program established in such subpart.
‘‘(d) DEFINITION.—For purposes of this section, the
term ‘diabetes in children’ includes Type 1 diabetes in
children and Type 2 diabetes in children.
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—For the
purpose of carrying out this section, there are authorized
to be appropriated such sums as may be necessary for
each of the fiscal years 2001 through 2005. Amounts
available for carrying out this section shall remain avail-
able until the expiration of the second fiscal year begin-
ning after the fiscal year for which the amounts were made
available.’’.
(g) AUTHORIZATION OF APPROPRIATIONS.—For the
purpose of carrying out this section, there are authorized
to be appropriated such sums as may be necessary for
each of the fiscal years 2001 through 2004.
Æ